Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly ...

Now, there could be another alternative, in the form of eye drops administered daily, according to AbbVie's Allergan subsidiary, which reported new phase 3 data for its pilocarpine formulation ...

inclusive of a $100M payment if the US FDA approves reproxalap for dry eye disease. This is a money saver deal for AbbVie and a Hail Mary pass for Aldeyra’s molecule. However, if you look at it ...

The company said it is keeping an eye on TNF-like ligand 1A (TL1A) therapies to be used in combination with Skyrizi which it hopes could become the new standard of care. AbbVie also spoke about ...

AbbVie will not be pursued any further by the US government over allegations that it used 'sham' litigation to keep competition to its AndroGel testosterone replacement product off the market.

Caplin Steriles, part of Caplin Point Laboratories, obtained final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) concerning the Brimonidine ...